{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:38:38Z","timestamp":1792557518532,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.09.037","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:25:14Z","timestamp":1791008714000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombin generation in critically ill adults: a systematic review of venous thromboembolism and pharmacological thromboprophylaxis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-0325","authenticated-orcid":false,"given":"Caseng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo ten","family":"Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.09.037_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2004.06.028","article-title":"The impact of the inflammatory response on coagulation","volume":"114","author":"Esmon","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.037_bib2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00134-025-08009-6","article-title":"Venous thromboprophylaxis in the ICU: navigating evidence, risk, and practice gaps","volume":"51","author":"Arabi","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2026.09.037_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005382","article-title":"Prognostic factors associated with development of venous thromboembolism in critically ill patients\u2014a systematic review and meta-analysis","volume":"50","author":"Tran","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2026.09.037_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chest.2021.08.050","article-title":"VTE prophylaxis in critically ill adults: a systematic review and network meta-analysis","volume":"161","author":"Fernando","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.09.037_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0310057X251397167","article-title":"Randomised controlled trials for the prevention of venous thromboembolism in critically ill patients: a systematic review of sample size methodologies","volume":"54","author":"Bitonti","year":"2026","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jtha.2026.09.037_bib6","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1161\/CIR.0000000000000769","article-title":"Call to action to prevent venous thromboembolism in hospitalized patients: a policy statement from the American Heart Association","volume":"141","author":"Henke","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.09.037_bib7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/CCM.0000000000007079","article-title":"Anti-Xa levels with venous thromboembolism prophylaxis in critical care: a systematic review and meta-analysis","volume":"54","author":"Durr","year":"2026","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2026.09.037_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2019.01.007","article-title":"Monitoring of heparins in antithrombin-deficient patients","volume":"175","author":"Croles","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.037_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100185","article-title":"The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin","volume":"7","author":"Sytema","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib10","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","article-title":"Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine","volume":"19","author":"Depasse","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293632","article-title":"Thrombin generation, bleeding and hemostasis in humans: protocol for a scoping review of the literature","volume":"18","author":"Shaw","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.09.037_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","article-title":"DOAC\u2013associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature","volume":"21","author":"Shaw","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2005.05612.x","article-title":"The measurement and application of thrombin generation","volume":"130","author":"Baglin","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.09.037_bib14","article-title":"Anti-factor Xa activity is not associated with venous thromboembolism in critically ill patients receiving enoxaparin for thromboprophylaxis: a retrospective observational study","volume":"9","author":"Dibiasi","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtha.2026.09.037_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-015-1003-9","article-title":"Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis","volume":"19","author":"Minet","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2026.09.037_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.09.037_bib17","series-title":"JBI manual for evidence synthesis","year":"2024"},{"key":"10.1016\/j.jtha.2026.09.037_bib18","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.09.037_bib19","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.09.037_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"La","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jtha.2026.09.037_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/aas.13748","article-title":"Utility of coagulation analyses to assess thromboprophylaxis with dalteparin in intensive care unit patients","volume":"65","author":"Andersen","year":"2021","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.jtha.2026.09.037_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2020.01.014","article-title":"Supplementation with antithrombin III ex vivo optimizes enoxaparin responses in critically injured patients","volume":"187","author":"Cardenas","year":"2020","journal-title":"Throm Res"},{"key":"10.1016\/j.jtha.2026.09.037_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/rth2.12483","article-title":"Exploring the utility of a novel point-of-care whole blood thrombin generation assay following trauma: a pilot study","volume":"5","author":"Ferrara","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib24","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41598-023-28474-7","article-title":"Age-dependent thrombin generation predicts 30-day mortality and symptomatic thromboembolism after multiple trauma","volume":"13","author":"Lesbo","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2026.09.037_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.surg.2019.04.014","article-title":"Early versus late venous thromboembolism: a secondary analysis of data from the PROPPR trial","volume":"166","author":"Myers","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jtha.2026.09.037_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/SHK.0000000000002526","article-title":"Increased citrullinated histone H3 levels and accelerated thrombin kinetics in trauma patients who develop venous thromboembolism","volume":"63","author":"Navarro","year":"2025","journal-title":"Shock"},{"key":"10.1016\/j.jtha.2026.09.037_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.surg.2011.12.022","article-title":"Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not","volume":"151","author":"Park","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.jtha.2026.09.037_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/TA.0000000000001466","article-title":"Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma: a prospective cohort study","volume":"83","author":"Park","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2026.09.037_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/aas.13697","article-title":"Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT","volume":"65","author":"Vahtera","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jtha.2026.09.037_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jamasurg.2022.2214","article-title":"Association of changes in antithrombin activity over time with responsiveness to enoxaparin prophylaxis and risk of trauma-related venous thromboembolism","volume":"157","author":"Vincent","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtha.2026.09.037_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2016.09.024","article-title":"Early thrombin formation capacity in trauma patients and association with venous thromboembolism","volume":"147","author":"Voils","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.037_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2125.2012.04285.x","article-title":"Bioactivity of enoxaparin in critically ill patients with normal renal function","volume":"74","author":"Gouya","year":"2012","journal-title":"Brit J Clinical Pharma"},{"key":"10.1016\/j.jtha.2026.09.037_bib33","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0041-1735454","article-title":"Dynamic hemostasis and fibrinolysis assays in intensive care COVID-19 patients and association with thrombosis and bleeding - a systematic review and a cohort study","volume":"48","author":"Hvas","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib35","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1111\/bjh.17003","article-title":"Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19","volume":"190","author":"Chistolini","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.09.037_bib36","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib37","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: communication from the ISTH SSC subcommittee on lupus anticoagulant\/antiphospholipid antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.037_bib38","series-title":"Hemostasis and thrombosis: methods and protocols","first-page":"343","article-title":"An overview of heparin monitoring with the Anti-Xa Assay","author":"Dean","year":"2023"},{"key":"10.1016\/j.jtha.2026.09.037_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4212\/cjhp.v68i1.1423","article-title":"Measuring anti\u2013factor Xa activity to monitor low-molecular-weight heparin in obesity: a critical review","volume":"68","author":"Egan","year":"2015","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jtha.2026.09.037_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109541","article-title":"Exploring anti-Xa activity and its correlation with C-reactive protein in intensive care unit patients receiving a therapeutic dosage of nadroparin","volume":"257","author":"Klein","year":"2026","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.037_bib41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/SLA.0000000000005754","article-title":"Efficacy and safety of anti-Xa-guided versus fixed dosing of low molecular weight heparin for prevention of venous thromboembolism in trauma patients: a systematic review and meta-analysis","volume":"277","author":"Tran","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtha.2026.09.037_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/TA.0000000000004326","article-title":"Prognostic factors associated with venous thromboembolism following traumatic injury: a systematic review and meta-analysis","volume":"97","author":"Tran","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2026.09.037_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/SLA.0000000000005157","article-title":"Efficacy and safety of low molecular weight heparin versus unfractionated heparin for prevention of venous thromboembolism in trauma patients: a systematic review and meta-analysis","volume":"275","author":"Tran","year":"2022","journal-title":"Ann Surg"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626006276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626006276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:44:56Z","timestamp":1792554296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626006276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S1538783626006276"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.037","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombin generation in critically ill adults: a systematic review of venous thromboembolism and pharmacological thromboprophylaxis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}